Sebaceous hyperplasia: systemic treatment with isotretinoin
نویسندگان
چکیده
منابع مشابه
Sebaceous hyperplasia: systemic treatment with isotretinoin*
The study aimed to verify the therapeutic action of isotretinoin in the treatment of sebaceous hyperplasia. During two months, 20 patients with sebaceous hyperplasia took isotretinoin at a dosage of 1mg/kg per day. Their skin lesions were counted and photographed before and after treatment and re-evaluated two years later. The average number of sebaceous hyperplasia lesions before treatment was...
متن کاملA Case of Cyclosporine-Induced Sebaceous Hyperplasia in a Renal Transplant Patient Successfully Treated with Isotretinoin.
Vol. 28, No. 2, 2016 271 Received December 2, 2014, Revised April 14, 2015, Accepted for publication May 12, 2015 Corresponding author: Hyun Jeong Park, Department of Dermatology, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 10 63-ro, Yeongdeungpo-gu, Seoul 07345, Korea. Tel: 82-2-3779-1230, Fax: 82-2-783-7604, E-mail: [email protected]. kr This is an Ope...
متن کاملPigmented trichoblastoma with sebaceous hyperplasia.
Trichoblastoma is a rare benign trichogenic tumour with epithelial and mesenchymal components recapitulating the germinal hair bulb and associated mesenchyme. A 50- year- old male patient presented with slowly enlarging circumscribed solid nodule measuring 4x3x4.5 cm over the tip of the nose. Microscopy of tumour revealed nodular tumour spanning the entire dermis with collection of mesenchymal ...
متن کاملTreatment of sebaceous gland hyperplasia with the pulsed dye laser.
BACKGROUND AND OBJECTIVE Sebaceous gland hyperplasia may be treated by cryotherapy, cauterization, topical chemicals, or excision. The major disadvantage of these therapeutic strategies is a considerable risk of postoperative scarring or dyspigmentation. The pulsed dye laser may be an effective and safe alternative treatment option. STUDY DESIGN AND METHODS Our report presents two patients wi...
متن کاملSystemic Isotretinoin for the Treatment of Acne
Oral isotretinoin (13-cis-retinoic acid) was first approved as treatment for severe acne by the US Food and Drug Administration (FDA) in 1982. To date the efficacy of isotretinoin has not been superseded by any other treatment and over two decades later isotretinoin remains the most clinically effective anti-acne therapy, producing long-term remission and/or significant improvement in many pati...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Anais Brasileiros de Dermatologia
سال: 2015
ISSN: 0365-0596
DOI: 10.1590/abd1806-4841.20153192